Preview | Issue Date | Title | Author(s) | Access |
![Healthcare Experience and their Relationship with Demographic.pdf.jpg](/jspui/retrieve/869eddaa-277e-4bf8-9cc5-934dca5a6959/Healthcare%20Experience%20and%c2%a0their%20Relationship%20with%c2%a0Demographic.pdf.jpg) | 2018 | Healthcare Experience and their Relationship with Demographic,
Disease and Healthcare‑Related Variables: A Cross‑Sectional Survey
of Patients with Chronic Diseases Using the IEXPAC Scale | Orozco-Beltrán, Domingo; de Toro, Javier; Galindo, María J.; Marín‑Jiménez, Ignacio; Casellas, Francesc; Fuster‑RuizdeApodaca, Maria J.; García‑Vivar7, María L.; Hormigo‑Pozo, Antonio; Guilabert, Mercedes; Sánchez‑Vega, Nuria; Fernandez, Gonzalo; Cea-Calvo, Luis | ![](/image/openAccess.png) |
![2023 Multidisciplinary Panel Consensus.pdf.jpg](/jspui/retrieve/9bacec71-738f-48b0-996f-16ef316e4a45/2023%20Multidisciplinary%20Panel%20Consensus.pdf.jpg) | 2024 | Multidisciplinary Panel Consensus for the Management of Patients with Type 2 Diabetes: A Delphi Study | Orozco-Beltrán, Domingo; Cebrián-Cuenca, Ana M.; Moreno-Pérez, Oscar; Campuzano-Ruiz, Raquel; Soler, Maria Jose; García de Lucas, M. Dolores | ![](/image/openAccess.png) |
![2022 Health care use.pdf.jpg](/jspui/retrieve/a789e69e-4db5-46dc-b066-a33a46efd1ee/2022%20Health%20care%20use.pdf.jpg) | 2022 | Healthcare use among people with
diabetes mellitus in Europe: a
population-based cross-sectional study | Fuentes-Merlos, Álvaro; Quesada-Rico, José Antonio; Reina, Raúl; Orozco-Beltrán, Domingo | ![](/image/openAccess.png) |
![2019 health care experience iexpac diabetes (1).pdf.jpg](/jspui/retrieve/d200793a-9c0d-4fe0-91ea-b1d1cd73ab1a/2019%20health%20care%20experience%20iexpac%20diabetes%20%281%29.pdf.jpg) | 2020 | Healthcare experience among patients with type 2 diabetes: A cross-sectional survey using the IEXPAC tool | Orozco-Beltrán, Domingo; Artola-Menéndez, Sara; Hormigo-Pozo, Antonio; Cararach-Salami, Daniel; Alonso-Jerez, Juan Luis; Álvaro-Grande, Epifanio; Villabrille-Arias, Covadonga; de Toro-Santos8, Francisco Javier; Galindo-Puerto, María José; Marín-Jiménez, Ignacio; Gómez-García, Antón; Ledesma-Rodriguez, Rocío; Fernández, Gonzalo; Ferreira de Campos, Karine | ![](/image/openAccess.png) |
![2018 Calculating individualized (1) (1).pdf.jpg](/jspui/retrieve/842a8799-44e8-4313-8e84-1e57b3814293/2018%20Calculating%20individualized%20%281%29%20%281%29.pdf.jpg) | 2017 | Calculating individualized glycaemic targets using an algorithm
based on expert worldwide diabetologists: Implications in real‐
life clinical practice | Alvarez‐Guisasola, Fernando; Cebrián‐Cuenca, Ana M.; Cos, Xavier; Ruiz‐Quintero, Manuel; Millaruelo, Jose M.; Cahn, Avivit; Raz, Itamar; Orozco‐Beltrán, Domingo | ![](/image/openAccess.png) |
![Endocrine disruption in Crohn’s disease Bisphenol A enhances.pdf.jpg](/jspui/retrieve/12c382c4-cccf-4be0-8c30-fd80a20136af/Endocrine%20disruption%20in%20Crohn%e2%80%99s%20disease%20Bisphenol%20A%20enhances.pdf.jpg) | 2021 | Endocrine disruption in Crohn’s disease: Bisphenol A enhances systemic inflammatory response in patients with gut barrier translocation of dysbiotic microbiota products | Linares, Raquel; Fernández, Mariana F.; Gutiérrez, Ana; García-Villalba, Rocío; Suárez, Beatriz; Martínez-Blázquez, José Alberto; Caparrós, Esther; Tomás-Barberán, Francisco A.; Francés, Rubén | ![](/image/openAccess.png) |
![Efficacy and safety of insulin glargine 300 UmL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2.pdf.jpg](/jspui/retrieve/99da0070-896d-4f33-8be7-9d4ebce6237b/Efficacy%20and%20safety%20of%20insulin%20glargine%20300%20UmL%20%28Gla-300%29%20during%20hospitalization%20and%20therapy%20intensification%20at%20discharge%20in%20patients%20with%20insufficiently%20controlled%20type%202.pdf.jpg) | 18-Jul-2020 | Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: results of the phase IV COBALTA trial | Perez, Antonio; Carrasco-Sánchez, Francisco Javier; González, Carlos; Seguí-Ripoll, José Miguel; Trescolí, Carlos; Ena, Javier; Borrell, Mireia; Gomez Huelgas, Ricardo | ![](/image/openAccess.png) |
![Dysbiotic microbiota interactions in Crohn’s.pdf.jpg](/jspui/retrieve/476c8498-9259-41ee-9fab-d40d1efbaba5/Dysbiotic%20microbiota%20interactions%20in%20Crohn%e2%80%99s.pdf.jpg) | 2021 | Dysbiotic microbiota interactions in Crohn’s disease | Caparrós, Esther; Wiest, Reiner; Scharl, Michael; Rogler, Gerhard; Gutiérrez Casbas, Ana; Yilmaz, Bahtiyar; Wawrzyniak, Marcin; Francés, Rubén | ![](/image/openAccess.png) |
![Severe skin reaction to imatinib in a case of Philadelphia-positive acute lymphoblastic.pdf.jpg](/jspui/retrieve/3387b5a6-bf14-4f30-84ac-16b9983020fa/Severe%20skin%20reaction%20to%20imatinib%20in%20a%20case%20of%20Philadelphia-positive%20acute%20lymphoblastic.pdf.jpg) | 2003 | Severe skin reaction to imatinib in a case of Philadelphia-positive acute lymphoblastic
leukemia | Sanchez-Gonzalez, Blanca; Pascual-Ramirez, Jose C.; Fernandez Abellan, Pascual; Belinchón , Isabel ; Rivas, Concepción; Vegara-Aguilera, Gloria | ![](/image/openAccess.png) |
![Transcriptional regulation of chemokine network by biologic monotherapy.pdf.jpg](/jspui/retrieve/06ad097f-3e35-4f9f-8563-cce6bf12b3cf/Transcriptional%20regulation%20of%20chemokine%20network%20by%20biologic%20monotherapy.pdf.jpg) | 2022 | Transcriptional regulation of chemokine network by biologic monotherapy in ileum of patients with Crohn’s disease | Linares, Raquel; Gutiérrez, Ana; Márquez-Galera, Ángel; Caparrós, Esther; Aparicio, José R.; Madero, Lucía; Payá, Artemio; López-Atalaya, José P.; Francés, Rubén | ![](/image/openAccess.png) |